Delivery Order SPE2DB22D2007-SPE2DB25FJ4UH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $51,681.12 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action issued under...
- The Defense Logistics Agency awarded a $12,329.16 delivery order to AmerisourceBergen Drug Corp for 28 capsules of Revlimid 5 mg on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a $27,425.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Revlimid 2.5 mg capsules (28-count units), with an ultimate completion date of September 29, 2025. This non-set-aside competitive award was issued on September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $53,251.31 to AmerisourceBergen Drug Corp for the supply of Revlimid 15 mg capsules (100-count units) on July 24, 2025, with completion expected by August 14, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at approximately $51.7K to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units). This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive procurement executed under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Revlimid 10 mg capsules (100-count units) with a ceiling value of $52,575.49. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, carries no set-aside designation and was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25.8K to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (quantity: 28 units) on August 14, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Revlimid 15 mg capsules (21-count packages) under a firm fixed-price contract with a ceiling value of $32,771.71. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 4, 2025, with fulfillment performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $52,487.80 by the Defense Logistics Agency on August 28, 2025, for the supply of Revlimid 25 mg capsules (100-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, and will be performed at the awardee's Conshohocken location. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $12,329.16 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (28-count) under a Firm Fixed Price contract with an ultimate completion date of September 3, 2025. This non-set-aside award was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4UHDelivery Order
The Defense Logistics Agency awarded a $51,089.97 delivery order to AmerisourceBergen Drug Corp for Revlimid 10 mg capsules (28-count) on September 9, 2025, with performance completion targeted for September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies the Defense Logistics Agency's Medical Supply Chain with an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The prime indefinite delivery contract serves as a comprehensive procurement vehicle enabling the contractor to supply pharmaceutical products and medical commodities to support military healthcare programs worldwide, with customer bases including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Revlimid represents a specific draw against this master contract vehicle to fulfill immediate pharmaceutical supply needs within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.1k | 9/9/25 |